The successful acquisition of AIM represents a major step forward in Graham's investment thesis to build a premier medical device manufacturing business.
Lawsuit alleges the companies submitted or caused false claims to Medicare for medically unnecessary glucometers and paid kickbacks to Medicare beneficiaries.